This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69420551
rdf:type
wikibase:Item
schema:description
article scientifique publié en 1987 wetenschappelijk artikel scientific article published on 01 January 1987 artículu científicu espublizáu en xineru de 1987 1987 թվականի հունվարի 1-ին հրատարակված գիտական հոդված im Januar 1987 veröffentlichter wissenschaftlicher Artikel artikull shkencor i botuar më 01 janar 1987 наукова стаття, опублікована в січні 1987
p:P577
wds:Q69420551-DCC15BCA-4BCD-4803-A8BE-7211CDFCD1B9
wdt:P577
1987-01-01T00:00:00Z
p:P2860
wds:Q69420551-6F1FFC1A-5E72-4B29-9B21-FDF747102033 wds:Q69420551-89F7207C-EF28-47AA-B769-6E23CAAB3ACA wds:Q69420551-45EF1841-A700-439C-A724-47D64A7F7B2E wds:Q69420551-D9A21120-6C7F-447B-ABEF-39B56C59D456
wdt:P2860
wd:Q72036773 wd:Q70789160 wd:Q71347049 wd:Q37000423
p:P2093
wds:Q69420551-9EE17F24-0BA5-4168-A9B0-C5A5EBB94095 wds:Q69420551-528CC67E-5BF0-4F0F-9849-8ED69356EB1B
wdt:P2093
H J Scherpbier H J Oosterhuis
rdfs:label
Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis
skos:prefLabel
Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis
schema:name
Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis
p:P1476
wds:Q69420551-E31B2ACF-22AD-4578-BA20-A1F85DBEBD62
wdt:P1476
Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis
p:P304
wds:Q69420551-B18D0CB1-783E-4C2D-AF0B-A488A59CF72D
wdt:P304
145-150
p:P31
wds:Q69420551-590C8ABC-05C1-403E-A16B-8031ED220AF5
wdt:P31
wd:Q13442814
p:P921
wds:Q69420551-2C45C48E-C665-4E59-B387-69E5CD32268F
wdt:P921
wd:Q8285
p:P698
wds:Q69420551-BF0893B1-61FC-44ED-8061-44B5A3087574
wdtn:P698
n12:3665287
wdt:P698
3665287
p:P1433
wds:Q69420551-86418999-1E27-4D5A-A010-3D3F91FEF866
wdt:P1433
wd:Q15763519
p:P433
wds:Q69420551-3B271375-8A87-4C31-8F49-F2639C607230
p:P478
wds:Q69420551-FD487BCD-F4D9-4E1D-B84E-1CCCF65EB2D6
wdt:P433
3
wdt:P478
89
p:P356
wds:Q69420551-D9D23EBC-86E5-491D-9F75-0937D1D5055F
wdtn:P356
n11:S0303-8467(87)80046-X
wdt:P356
10.1016/S0303-8467(87)80046-X